NOT-NS-14-008: Notice of Correction of NINDS's CFDA number in PAR-13-278 "NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)"

Notice of Correction of NINDS's CFDA number in PAR-13-278 "NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)"

Notice Number: NOT-NS-14-008

Update: The following update relating to this announcement has been issued:

March 4, 2014 - See Notice NOT-NS-14-017. Notice to Correct the NINDS CFDA Number Associated with this FOA, a new application package has been posted.

Key Dates
Release Date: January 16, 2014

Related Announcements
PAR-13-278

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The National Institute of Neurological Disorders and Stroke (NINDS) is correcting the CFDA number associated with PAR13-278 "NINDS Phase III Investigator-Initiated Efficacy Clinical Trials (U01)". The CFDA number should read:

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.853

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Wendy Galpern, MD, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
Email: [email protected]